Research Article
Fluconazole-Pyridoxine Bis-Triazolium Compounds with Potent Activity against Pathogenic Bacteria and Fungi Including Their Biofilm-Embedded Forms
Table 2
In vitro antibacterial activity of the obtained compounds
4a,b and the reference drugs (MICs,
μg/mL)
| Compounds | Gram (+) | Gram (−) | S. aureus АТСС 29213 | B. subtilis 168 | S. epidermidis | M. luteus | E. coli АТСС 25922 | K. pneumoniae | P. aeruginosa АТСС 27853 | S. typhimurium TA100 |
| 4a | >64 | 32 | 32 | n.m. | >64 | >64 | >64 | n.m. | 4b | 0.5 | 2 | 8 | 4 | 16 | 32 | 32 | 8 | 4b + CaCl2 | >64 | >64 | >64 | n.m. | >64 | >64 | >64 | n.m. | Fluconazole | >64 | >64 | >64 | n.m. | >64 | >64 | >64 | n.m. | Terbinafine | >64 | >64 | >64 | n.m. | >64 | >64 | >64 | n.m. | Benzalkonium chloride | 4 | 2 | 8 | 4 | 16 | >64 | 32 | 8 | Miramistin | 2 | 1 | 4 | 4 | 8 | n.m. | 64 | 4 |
|
|
.m., not measured.
|